Prostate Cancer Screening Study

NIIM has recently developed a New Blood Test shown to markedly improve the early detection of Prostate Cancer.

The new improved Prostate Cancer Screening Test combines the ISET®-Circulating Tumour Cells (CTC) Test with Prostate Specific Antigen (PSA) marker testing achieving a more than 97% accuracy.

The New Prostate Cancer Screening Test has an estimated positive-predictive-value (PPV) of 99% and negative-predictive-value (NPV) of 97%.

This is in contrast to the less accurate standard PSA-blood-test, which provides a PPV or true positives of approximately 25% and NPV of 15.5%.

Prostate cancer is the most common in men, and the second leading cause of cancer deaths (22%) in Australia.2.

One-in-Seven Australian men will be diagnosed with prostate cancer by aged 85, with more than 3,300 men dying each year. This number is rising, suggesting the need for a more reliable and accurate way to diagnose the disease.

1. https://niim-rebuild.newpathstudio.com.au/researches/circulating-tumour-cells-ctc-study/

2. Prostate cancer in Australia. Data available via
https://www.canceraustralia.gov.au/affected-cancer/cancer-types/prostate-cancer/statistics 

pathogen-poster

New improved Prostate Cancer Screening Test published in

Frontiers in Oncology April 2020, 10, 582.

Cal For Participants

For the next phase of our research we are SEEKING 50-75 YEAR OLD MALES who would like to participate in this larger study of 500 participants.

The study will involve a simple blood test requiring 5-10 min of your time.

The blood test will provide your doctor with some information about the probability of detecting prostate cancer.

You will be encouraged to discuss the results of the NEW PROSTATE CANCER SCREENING TEST with your doctor.

For local participants (Melbourne, VIC): you can have your blood taken at the NIIM Clinic, Hawthorn.

For interstate participants (Aus): a test kit can be sent to you/ your doctor

For more information

or email directly to:[email protected] / Subject heading: Prostate Screening Test Study

News

ABC News interview with A/Prof Karin Ried discussing the NIIM Prostate Cancer Screening Study

Watch A/Prof Dr Karin Ried on Movember and the Prostate Cancer Screening Study – Nov, 2020s

Unlocking Nature’s Secret: How Phytoestrogens Can Ease Your Menopause Journey

Unlocking Nature’s Secret: How Phytoestrogens Can Ease Your Menopause Journey

If you’re a woman in your mid-40’s to mid-50’s experiencing night sweats, hot flushes, mood swings, insomnia, unexplained weight gain, irregular periods and abnormally heavy periods, you may be peri menopausal.

Read More
New Approaches to Mental Health: Depression, Anxiety, Addiction, PTSD and more

New Approaches to Mental Health: Depression, Anxiety, Addiction, PTSD and more

Join Mind Medicine Australia and NIIM at this public event to learn why psychedelic therapies are being hailed as potentially ground-breaking treatments for mental illness.

Read More

More Research We're Conducting

New Studies Seeking participants

Rife Frequency Study

This study uses Electro-Magnetic-Frequency Therapy (EMF), for the treatment of cancer and/or pathogens, and Circulating Tumour Cell (CTC) blood testing to assess EMF treatment effectiveness.

Ongoing Studies

The Gluco-Metabolism Study

12-week randomised placebo-controlled trial investigating the tolerability and effectiveness of the Nutrition Care Gluco-Metabolism herbal Formula on blood glucose levels.

New Studies Not taking participants

The Cognitive Preservation Study

This study aims to analyse the effect of Red Light Therapy, with or without additional Hyperbaric Oxygen Therapy, on cognition and brain health in people with mild and moderate cognitive impairment.